| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BST1 | CD38 | ENSSSCP00000067218 | ENSSSCP00000060180 | Bone marrow stromal cell antigen 1. | Uncharacterized protein. | 0.920 |
| BST1 | NAMPT | ENSSSCP00000067218 | ENSSSCP00000043109 | Bone marrow stromal cell antigen 1. | Nicotinamide phosphoribosyltransferase; Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock fun [...] | 0.944 |
| BST1 | NNMT | ENSSSCP00000067218 | ENSSSCP00000015979 | Bone marrow stromal cell antigen 1. | Nicotinamide N-methyltransferase; Catalyzes the N-methylation of nicotinamide and other pyridines to form pyridinium ions. This activity is important for biotransformation of many drugs and xenobiotic compounds (By similarity); Belongs to the class I-like SAM-binding methyltransferase superfamily. NNMT/PNMT/TEMT family. | 0.928 |
| BST1 | PNP | ENSSSCP00000067218 | ENSSSCP00000002333 | Bone marrow stromal cell antigen 1. | Purine nucleoside phosphorylase; The purine nucleoside phosphorylases catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta- (deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate. | 0.929 |
| BST1 | SARM1 | ENSSSCP00000067218 | ENSSSCP00000025709 | Bone marrow stromal cell antigen 1. | NAD(+) hydrolase SARM1; NAD(+) hydrolase, which plays a key role in axonal degeneration following injury by regulating NAD(+) metabolism (By similarity). Acts as a negative regulator of MYD88- and TRIF-dependent toll-like receptor signaling pathway by promoting Wallerian degeneration, an injury-induced form of programmed subcellular death which involves degeneration of an axon distal to the injury site. Wallerian degeneration is triggered by NAD(+) depletion: in response to injury, SARM1 is activated and catalyzes cleavage of NAD(+) into ADP-D-ribose (ADPR), cyclic ADPR (cADPR) and nic [...] | 0.957 |
| BST1 | SIRT1 | ENSSSCP00000067218 | ENSSSCP00000010911 | Bone marrow stromal cell antigen 1. | NAD-dependent protein deacetylase sirtuin-1 isoform a. | 0.929 |
| BST1 | SIRT3 | ENSSSCP00000067218 | ENSSSCP00000070969 | Bone marrow stromal cell antigen 1. | NAD-dependent protein deacetylase; NAD-dependent protein deacetylase. | 0.929 |
| BST1 | SIRT4 | ENSSSCP00000067218 | ENSSSCP00000074282 | Bone marrow stromal cell antigen 1. | NAD-dependent protein lipoamidase sirtuin-4, mitochondrial; Acts as NAD-dependent protein lipoamidase, ADP-ribosyl transferase and deacetylase. Catalyzes more efficiently removal of lipoyl- and biotinyl- than acetyl-lysine modifications. Inhibits the pyruvate dehydrogenase complex (PDH) activity via the enzymatic hydrolysis of the lipoamide cofactor from the E2 component, DLAT, in a phosphorylation-independent manner. Catalyzes the transfer of ADP- ribosyl groups onto target proteins, including mitochondrial GLUD1, inhibiting GLUD1 enzyme activity. Acts as a negative regulator of mitoc [...] | 0.927 |
| BST1 | SIRT6 | ENSSSCP00000067218 | ENSSSCP00000014350 | Bone marrow stromal cell antigen 1. | Deacetylase sirtuin-type domain-containing protein. | 0.930 |
| BST1 | SIRT7 | ENSSSCP00000067218 | ENSSSCP00000038246 | Bone marrow stromal cell antigen 1. | Sirtuin 7. | 0.935 |
| CD38 | BST1 | ENSSSCP00000060180 | ENSSSCP00000067218 | Uncharacterized protein. | Bone marrow stromal cell antigen 1. | 0.920 |
| CD38 | NAMPT | ENSSSCP00000060180 | ENSSSCP00000043109 | Uncharacterized protein. | Nicotinamide phosphoribosyltransferase; Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock fun [...] | 0.952 |
| CD38 | NNMT | ENSSSCP00000060180 | ENSSSCP00000015979 | Uncharacterized protein. | Nicotinamide N-methyltransferase; Catalyzes the N-methylation of nicotinamide and other pyridines to form pyridinium ions. This activity is important for biotransformation of many drugs and xenobiotic compounds (By similarity); Belongs to the class I-like SAM-binding methyltransferase superfamily. NNMT/PNMT/TEMT family. | 0.934 |
| CD38 | PNP | ENSSSCP00000060180 | ENSSSCP00000002333 | Uncharacterized protein. | Purine nucleoside phosphorylase; The purine nucleoside phosphorylases catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta- (deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate. | 0.934 |
| CD38 | SARM1 | ENSSSCP00000060180 | ENSSSCP00000025709 | Uncharacterized protein. | NAD(+) hydrolase SARM1; NAD(+) hydrolase, which plays a key role in axonal degeneration following injury by regulating NAD(+) metabolism (By similarity). Acts as a negative regulator of MYD88- and TRIF-dependent toll-like receptor signaling pathway by promoting Wallerian degeneration, an injury-induced form of programmed subcellular death which involves degeneration of an axon distal to the injury site. Wallerian degeneration is triggered by NAD(+) depletion: in response to injury, SARM1 is activated and catalyzes cleavage of NAD(+) into ADP-D-ribose (ADPR), cyclic ADPR (cADPR) and nic [...] | 0.947 |
| CD38 | SIRT1 | ENSSSCP00000060180 | ENSSSCP00000010911 | Uncharacterized protein. | NAD-dependent protein deacetylase sirtuin-1 isoform a. | 0.945 |
| CD38 | SIRT3 | ENSSSCP00000060180 | ENSSSCP00000070969 | Uncharacterized protein. | NAD-dependent protein deacetylase; NAD-dependent protein deacetylase. | 0.935 |
| CD38 | SIRT4 | ENSSSCP00000060180 | ENSSSCP00000074282 | Uncharacterized protein. | NAD-dependent protein lipoamidase sirtuin-4, mitochondrial; Acts as NAD-dependent protein lipoamidase, ADP-ribosyl transferase and deacetylase. Catalyzes more efficiently removal of lipoyl- and biotinyl- than acetyl-lysine modifications. Inhibits the pyruvate dehydrogenase complex (PDH) activity via the enzymatic hydrolysis of the lipoamide cofactor from the E2 component, DLAT, in a phosphorylation-independent manner. Catalyzes the transfer of ADP- ribosyl groups onto target proteins, including mitochondrial GLUD1, inhibiting GLUD1 enzyme activity. Acts as a negative regulator of mitoc [...] | 0.931 |
| CD38 | SIRT6 | ENSSSCP00000060180 | ENSSSCP00000014350 | Uncharacterized protein. | Deacetylase sirtuin-type domain-containing protein. | 0.941 |
| CD38 | SIRT7 | ENSSSCP00000060180 | ENSSSCP00000038246 | Uncharacterized protein. | Sirtuin 7. | 0.951 |
